TABLE OF CONTENTS 1 Research Methodology and Statistical Scope 1.1 Market Definition and Statistical Scope of Antidiabetic Drug 1.2 Key Market Segments 1.2.1 Antidiabetic Drug Segment by Type 1.2.2 Antidiabetic Drug Segment by Application 1.3 Methodology & Sources of Information 1.3.1 Research Methodology 1.3.2 Research Process 1.3.3 Market Breakdown and Data Triangulation 1.3.4 Base Year 1.3.5 Report Assumptions & Caveats 2 Antidiabetic Drug Market Overview 2.1 Global Market Overview 2.1.1 Global Antidiabetic Drug Market Size (M USD) Estimates and Forecasts (2017-2028) 2.1.2 Global Antidiabetic Drug Sales Estimates and Forecasts (2017-2028) 2.2 Market Segment Executive Summary 2.3 Global Market Size by Region 3 Antidiabetic Drug Market Competitive Landscape 3.1 Global Antidiabetic Drug Sales by Manufacturers (2017-2022) 3.2 Global Antidiabetic Drug Revenue Market Share by Manufacturers (2017-2022) 3.3 Antidiabetic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4 Global Antidiabetic Drug Average Price by Manufacturers (2017-2022) 3.5 Manufacturers Antidiabetic Drug Sales Sites, Area Served, Product Type 3.6 Antidiabetic Drug Market Competitive Situation and Trends 3.6.1 Antidiabetic Drug Market Concentration Rate 3.6.2 Global 5 and 10 Largest Antidiabetic Drug Players Market Share by Revenue 3.6.3 Mergers & Acquisitions, Expansion 4 Antidiabetic Drug Industry Chain Analysis 4.1 Antidiabetic Drug Industry Chain Analysis 4.2 Market Overview and Market Concentration Analysis of Key Raw Materials 4.3 Midstream Market Analysis 4.4 Downstream Customer Analysis 5 The Development and Dynamics of Antidiabetic Drug Market 5.1 Key Development Trends 5.2 Driving Factors 5.3 Market Challenges 5.4 Market Restraints 5.5 Industry News 5.5.1 New Product Developments 5.5.2 Mergers & Acquisitions 5.5.3 Expansions 5.5.4 Collaboration/Supply Contracts 5.6 Industry Policies 6 Antidiabetic Drug Market Segmentation by Type 6.1 Evaluation Matrix of Segment Market Development Potential (Type) 6.2 Global Antidiabetic Drug Sales Market Share by Type (2017-2022) 6.3 Global Antidiabetic Drug Market Size Market Share by Type (2017-2022) 6.4 Global Antidiabetic Drug Price by Type (2017-2022) 7 Antidiabetic Drug Market Segmentation by Application 7.1 Evaluation Matrix of Segment Market Development Potential (Application) 7.2 Global Antidiabetic Drug Market Sales by Application (2017-2022) 7.3 Global Antidiabetic Drug Market Size (M USD) by Application (2017-2022) 7.4 Global Antidiabetic Drug Sales Growth Rate by Application (2017-2022) 8 Antidiabetic Drug Market Segmentation by Region 8.1 Global Antidiabetic Drug Sales by Region 8.1.1 Global Antidiabetic Drug Sales by Region 8.1.2 Global Antidiabetic Drug Sales Market Share by Region 8.2 North America 8.2.1 North America Antidiabetic Drug Sales by Country 8.2.2 U.S. 8.2.3 Canada 8.2.4 Mexico 8.3 Europe 8.3.1 Europe Antidiabetic Drug Sales by Country 8.3.2 Germany 8.3.3 France 8.3.4 U.K. 8.3.5 Italy 8.3.6 Russia 8.4 Asia Pacific 8.4.1 Asia Pacific Antidiabetic Drug Sales by Region 8.4.2 China 8.4.3 Japan 8.4.4 South Korea 8.4.5 India 8.4.6 Southeast Asia 8.5 South America 8.5.1 South America Antidiabetic Drug Sales by Country 8.5.2 Brazil 8.5.3 Argentina 8.5.4 Columbia 8.6 Middle East and Africa 8.6.1 Middle East and Africa Antidiabetic Drug Sales by Region 8.6.2 Saudi Arabia 8.6.3 UAE 8.6.4 Egypt 8.6.5 Nigeria 8.6.6 South Africa 9 Key Companies Profiled 9.1 Sanofi-Aventis 9.1.1 Sanofi-Aventis Antidiabetic Drug Basic Information 9.1.2 Sanofi-Aventis Antidiabetic Drug Product Overview 9.1.3 Sanofi-Aventis Antidiabetic Drug Product Market Performance 9.1.4 Sanofi-Aventis Business Overview 9.1.5 Sanofi-Aventis Antidiabetic Drug SWOT Analysis 9.1.6 Sanofi-Aventis Recent Developments 9.2 Eli Lilly 9.2.1 Eli Lilly Antidiabetic Drug Basic Information 9.2.2 Eli Lilly Antidiabetic Drug Product Overview 9.2.3 Eli Lilly Antidiabetic Drug Product Market Performance 9.2.4 Eli Lilly Business Overview 9.2.5 Eli Lilly Antidiabetic Drug SWOT Analysis 9.2.6 Eli Lilly Recent Developments 9.3 Oramed 9.3.1 Oramed Antidiabetic Drug Basic Information 9.3.2 Oramed Antidiabetic Drug Product Overview 9.3.3 Oramed Antidiabetic Drug Product Market Performance 9.3.4 Oramed Business Overview 9.3.5 Oramed Antidiabetic Drug SWOT Analysis 9.3.6 Oramed Recent Developments 9.4 Takeda 9.4.1 Takeda Antidiabetic Drug Basic Information 9.4.2 Takeda Antidiabetic Drug Product Overview 9.4.3 Takeda Antidiabetic Drug Product Market Performance 9.4.4 Takeda Business Overview 9.4.5 Takeda Antidiabetic Drug SWOT Analysis 9.4.6 Takeda Recent Developments 9.5 Boehringer Ingelheim 9.5.1 Boehringer Ingelheim Antidiabetic Drug Basic Information 9.5.2 Boehringer Ingelheim Antidiabetic Drug Product Overview 9.5.3 Boehringer Ingelheim Antidiabetic Drug Product Market Performance 9.5.4 Boehringer Ingelheim Business Overview 9.5.5 Boehringer Ingelheim Antidiabetic Drug SWOT Analysis 9.5.6 Boehringer Ingelheim Recent Developments 9.6 Novo Nordisk 9.6.1 Novo Nordisk Antidiabetic Drug Basic Information 9.6.2 Novo Nordisk Antidiabetic Drug Product Overview 9.6.3 Novo Nordisk Antidiabetic Drug Product Market Performance 9.6.4 Novo Nordisk Business Overview 9.6.5 Novo Nordisk Recent Developments 9.7 Halozyme Therapeutics 9.7.1 Halozyme Therapeutics Antidiabetic Drug Basic Information 9.7.2 Halozyme Therapeutics Antidiabetic Drug Product Overview 9.7.3 Halozyme Therapeutics Antidiabetic Drug Product Market Performance 9.7.4 Halozyme Therapeutics Business Overview 9.7.5 Halozyme Therapeutics Recent Developments 9.8 Bristol-Myers Squibb 9.8.1 Bristol-Myers Squibb Antidiabetic Drug Basic Information 9.8.2 Bristol-Myers Squibb Antidiabetic Drug Product Overview 9.8.3 Bristol-Myers Squibb Antidiabetic Drug Product Market Performance 9.8.4 Bristol-Myers Squibb Business Overview 9.8.5 Bristol-Myers Squibb Recent Developments 9.9 Pfizer 9.9.1 Pfizer Antidiabetic Drug Basic Information 9.9.2 Pfizer Antidiabetic Drug Product Overview 9.9.3 Pfizer Antidiabetic Drug Product Market Performance 9.9.4 Pfizer Business Overview 9.9.5 Pfizer Recent Developments 9.10 Tonghua Dongbao 9.10.1 Tonghua Dongbao Antidiabetic Drug Basic Information 9.10.2 Tonghua Dongbao Antidiabetic Drug Product Overview 9.10.3 Tonghua Dongbao Antidiabetic Drug Product Market Performance 9.10.4 Tonghua Dongbao Business Overview 9.10.5 Tonghua Dongbao Recent Developments 9.11 Biocon 9.11.1 Biocon Antidiabetic Drug Basic Information 9.11.2 Biocon Antidiabetic Drug Product Overview 9.11.3 Biocon Antidiabetic Drug Product Market Performance 9.11.4 Biocon Business Overview 9.11.5 Biocon Recent Developments 9.12 Wockhardt 9.12.1 Wockhardt Antidiabetic Drug Basic Information 9.12.2 Wockhardt Antidiabetic Drug Product Overview 9.12.3 Wockhardt Antidiabetic Drug Product Market Performance 9.12.4 Wockhardt Business Overview 9.12.5 Wockhardt Recent Developments 10 Antidiabetic Drug Market Forecast by Region 10.1 Global Antidiabetic Drug Market Size Forecast 10.2 Global Antidiabetic Drug Market Forecast by Region 10.2.1 North America Market Size Forecast by Country 10.2.2 Europe Antidiabetic Drug Market Size Forecast by Country 10.2.3 Asia Pacific Antidiabetic Drug Market Size Forecast by Region 10.2.4 South America Antidiabetic Drug Market Size Forecast by Country 10.2.5 Middle East and Africa Forecasted Consumption of Antidiabetic Drug by Country 11 Forecast Market by Type and by Application (2022-2028) 11.1 Global Antidiabetic Drug Market Forecast by Type (2022-2028) 11.1.1 Global Forecasted Sales of Antidiabetic Drug by Type (2022-2028) 11.1.2 Global Antidiabetic Drug Market Size Forecast by Type (2022-2028) 11.1.3 Global Forecasted Price of Antidiabetic Drug by Type (2022-2028) 11.2 Global Antidiabetic Drug Market Forecast by Application (2022-2028) 11.2.1 Global Antidiabetic Drug Sales (K Units) Forecast by Application 11.2.2 Global Antidiabetic Drug Market Size (M USD) Forecast by Application (2022-2028) 12 Conclusion and Key Findings

LIST OF TABLES Table 1. Introduction of the Type Table 2. Introduction of the Application Table 3. Market Size (M USD) Segment Executive Summary Table 4. Antidiabetic Drug Market Size (M USD) Comparison by Region (M USD) Table 5. Global Antidiabetic Drug Sales (K Units) by Manufacturers (2017-2022) Table 6. Global Antidiabetic Drug Sales Market Share by Manufacturers (2017-2022) Table 7. Global Antidiabetic Drug Revenue (M USD) by Manufacturers (2017-2022) Table 8. Global Antidiabetic Drug Revenue Share by Manufacturers (2017-2022) Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antidiabetic Drug as of 2021) Table 10. Global Market Antidiabetic Drug Average Price (USD/Unit) of Key Manufacturers (2017-2022) Table 11. Manufacturers Antidiabetic Drug Sales Sites and Area Served Table 12. Manufacturers Antidiabetic Drug Product Type Table 13. Global Antidiabetic Drug Manufacturers Market Concentration Ratio (CR5 and HHI) Table 14. Mergers & Acquisitions, Expansion Plans Table 15. Industry Chain Map of Antidiabetic Drug Table 16. Raw Materials Table 17. Midstream Market Analysis Table 18. Downstream Customer Analysis Table 19. Key Development Trends Table 20. Driving Factors Table 21. Antidiabetic Drug Market Challenges Table 22. Market Restraints Table 23. Global Antidiabetic Drug Sales by Type (K Units) Table 24. Global Antidiabetic Drug Market Size by Type (M USD) Table 25. Global Antidiabetic Drug Sales (K Units) by Type (2017-2022) Table 26. Global Antidiabetic Drug Sales Market Share by Type (2017-2022) Table 27. Global Antidiabetic Drug Market Size (M USD) by Type (2017-2022) Table 28. Global Antidiabetic Drug Market Size Share by Type (2017-2022) Table 29. Global Antidiabetic Drug Price (USD/Unit) by Type (2017-2022) Table 30. Global Antidiabetic Drug Sales (K Units) by Application Table 31. Global Antidiabetic Drug Market Size by Application Table 32. Global Antidiabetic Drug Sales by Application (2017-2022) & (K Units) Table 33. Global Antidiabetic Drug Sales Market Share by Application (2017-2022) Table 34. Global Antidiabetic Drug Sales by Application (2017-2022) & (M USD) Table 35. Global Antidiabetic Drug Market Share by Application (2017-2022) Table 36. Global Antidiabetic Drug Sales Growth Rate by Application (2017-2022) Table 37. Global Antidiabetic Drug Sales by Region (2017-2022) & (K Units) Table 38. Global Antidiabetic Drug Sales Market Share by Region (2017-2022) Table 39. North America Antidiabetic Drug Sales by Country (2017-2022) & (K Units) Table 40. Europe Antidiabetic Drug Sales by Country (2017-2022) & (K Units) Table 41. Asia Pacific Antidiabetic Drug Sales by Region (2017-2022) & (K Units) Table 42. South America Antidiabetic Drug Sales by Country (2017-2022) & (K Units) Table 43. Middle East and Africa Antidiabetic Drug Sales by Region (2017-2022) & (K Units) Table 44. Sanofi-Aventis Antidiabetic Drug Basic Information Table 45. Sanofi-Aventis Antidiabetic Drug Product Overview Table 46. Sanofi-Aventis Antidiabetic Drug Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 47. Sanofi-Aventis Business Overview Table 48. Sanofi-Aventis Antidiabetic Drug SWOT Analysis Table 49. Sanofi-Aventis Recent Developments Table 50. Eli Lilly Antidiabetic Drug Basic Information Table 51. Eli Lilly Antidiabetic Drug Product Overview Table 52. Eli Lilly Antidiabetic Drug Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 53. Eli Lilly Business Overview Table 54. Eli Lilly Antidiabetic Drug SWOT Analysis Table 55. Eli Lilly Recent Developments Table 56. Oramed Antidiabetic Drug Basic Information Table 57. Oramed Antidiabetic Drug Product Overview Table 58. Oramed Antidiabetic Drug Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 59. Oramed Business Overview Table 60. Oramed Antidiabetic Drug SWOT Analysis Table 61. Oramed Recent Developments Table 62. Takeda Antidiabetic Drug Basic Information Table 63. Takeda Antidiabetic Drug Product Overview Table 64. Takeda Antidiabetic Drug Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 65. Takeda Business Overview Table 66. Takeda Antidiabetic Drug SWOT Analysis Table 67. Takeda Recent Developments Table 68. Boehringer Ingelheim Antidiabetic Drug Basic Information Table 69. Boehringer Ingelheim Antidiabetic Drug Product Overview Table 70. Boehringer Ingelheim Antidiabetic Drug Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 71. Boehringer Ingelheim Business Overview Table 72. Boehringer Ingelheim Antidiabetic Drug SWOT Analysis Table 73. Boehringer Ingelheim Recent Developments Table 74. Novo Nordisk Antidiabetic Drug Basic Information Table 75. Novo Nordisk Antidiabetic Drug Product Overview Table 76. Novo Nordisk Antidiabetic Drug Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 77. Novo Nordisk Business Overview Table 78. Novo Nordisk Recent Developments Table 79. Halozyme Therapeutics Antidiabetic Drug Basic Information Table 80. Halozyme Therapeutics Antidiabetic Drug Product Overview Table 81. Halozyme Therapeutics Antidiabetic Drug Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 82. Halozyme Therapeutics Business Overview Table 83. Halozyme Therapeutics Recent Developments Table 84. Bristol-Myers Squibb Antidiabetic Drug Basic Information Table 85. Bristol-Myers Squibb Antidiabetic Drug Product Overview Table 86. Bristol-Myers Squibb Antidiabetic Drug Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 87. Bristol-Myers Squibb Business Overview Table 88. Bristol-Myers Squibb Recent Developments Table 89. Pfizer Antidiabetic Drug Basic Information Table 90. Pfizer Antidiabetic Drug Product Overview Table 91. Pfizer Antidiabetic Drug Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 92. Pfizer Business Overview Table 93. Pfizer Recent Developments Table 94. Tonghua Dongbao Antidiabetic Drug Basic Information Table 95. Tonghua Dongbao Antidiabetic Drug Product Overview Table 96. Tonghua Dongbao Antidiabetic Drug Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 97. Tonghua Dongbao Business Overview Table 98. Tonghua Dongbao Recent Developments Table 99. Biocon Antidiabetic Drug Basic Information Table 100. Biocon Antidiabetic Drug Product Overview Table 101. Biocon Antidiabetic Drug Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 102. Biocon Business Overview Table 103. Biocon Recent Developments Table 104. Wockhardt Antidiabetic Drug Basic Information Table 105. Wockhardt Antidiabetic Drug Product Overview Table 106. Wockhardt Antidiabetic Drug Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 107. Wockhardt Business Overview Table 108. Wockhardt Recent Developments Table 109. Global Antidiabetic Drug Sales Forecast by Region (K Units) Table 110. Global Antidiabetic Drug Market Size Forecast by Region (M USD) Table 111. North America Antidiabetic Drug Sales Forecast by Country (2022-2028) & (K Units) Table 112. North America Antidiabetic Drug Market Size Forecast by Country (2022-2028) & (M USD) Table 113. Europe Antidiabetic Drug Sales Forecast by Country (2022-2028) & (K Units) Table 114. Europe Antidiabetic Drug Market Size Forecast by Country (2022-2028) & (M USD) Table 115. Asia Pacific Antidiabetic Drug Sales Forecast by Region (2022-2028) & (K Units) Table 116. Asia Pacific Antidiabetic Drug Market Size Forecast by Region (2022-2028) & (M USD) Table 117. South America Antidiabetic Drug Sales Forecast by Country (2022-2028) & (K Units) Table 118. South America Antidiabetic Drug Market Size Forecast by Country (2022-2028) & (M USD) Table 119. Middle East and Africa Antidiabetic Drug Consumption Forecast by Country (2022-2028) & (Units) Table 120. Middle East and Africa Antidiabetic Drug Market Size Forecast by Country (2022-2028) & (M USD) Table 121. Global Antidiabetic Drug Sales Forecast by Type (2022-2028) & (K Units) Table 122. Global Antidiabetic Drug Market Size Forecast by Type (2022-2028) & (M USD) Table 123. Global Antidiabetic Drug Price Forecast by Type (2022-2028) & (USD/Unit) Table 124. Global Antidiabetic Drug Sales (K Units) Forecast by Application (2022-2028) Table 125. Global Antidiabetic Drug Market Size Forecast by Application (2022-2028) & (M USD) LIST OF FIGURES Figure 1. Product Picture of Antidiabetic Drug Figure 2. Data Triangulation Figure 3. Key Caveats Figure 4. Global Antidiabetic Drug Market Size (M USD), 2017-2028 Figure 5. Global Antidiabetic Drug Market Size (M USD) (2017-2028) Figure 6. Global Antidiabetic Drug Sales (K Units) & (2017-2028) Figure 7. Evaluation Matrix of Segment Market Development Potential (Type) Figure 8. Evaluation Matrix of Segment Market Development Potential (Application) Figure 9. Evaluation Matrix of Regional Market Development Potential Figure 10. Antidiabetic Drug Market Size (M USD) by Country (M USD) Figure 11. Antidiabetic Drug Sales Share by Manufacturers in 2020 Figure 12. Global Antidiabetic Drug Revenue Share by Manufacturers in 2020 Figure 13. Antidiabetic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 14. Global Market Antidiabetic Drug Average Price (USD/Unit) of Key Manufacturers in 2020 Figure 15. The Global 5 and 10 Largest Players: Market Share by Antidiabetic Drug Revenue in 2021 Figure 16. Evaluation Matrix of Segment Market Development Potential (Type) Figure 17. Global Antidiabetic Drug Market Share by Type Figure 18. Sales Market Share of Antidiabetic Drug by Type (2017-2022) Figure 19. Sales Market Share of Antidiabetic Drug by Type in 2021 Figure 20. Market Size Share of Antidiabetic Drug by Type (2017-2022) Figure 21. Market Size Market Share of Antidiabetic Drug by Type in 2020 Figure 22. Evaluation Matrix of Segment Market Development Potential (Application) Figure 23. Global Antidiabetic Drug Market Share by Application Figure 24. Global Antidiabetic Drug Sales Market Share by Application (2017-2022) Figure 25. Global Antidiabetic Drug Sales Market Share by Application in 2021 Figure 26. Global Antidiabetic Drug Market Share by Application (2017-2022) Figure 27. Global Antidiabetic Drug Market Share by Application in 2020 Figure 28. Global Antidiabetic Drug Sales Growth Rate by Application (2017-2022) Figure 29. Global Antidiabetic Drug Sales Market Share by Region (2017-2022) Figure 30. North America Antidiabetic Drug Sales and Growth Rate (2017-2022) & (K Units) Figure 31. North America Antidiabetic Drug Sales Market Share by Country in 2020 Figure 32. U.S. Antidiabetic Drug Sales and Growth Rate (2017-2022) & (K Units) Figure 33. Canada Antidiabetic Drug Sales (K Units) and Growth Rate (2017-2022) Figure 34. Mexico Antidiabetic Drug Sales (Units) and Growth Rate (2017-2022) Figure 35. Europe Antidiabetic Drug Sales and Growth Rate (2017-2022) & (K Units) Figure 36. Europe Antidiabetic Drug Sales Market Share by Country in 2020 Figure 37. Germany Antidiabetic Drug Sales and Growth Rate (2017-2022) & (K Units) Figure 38. France Antidiabetic Drug Sales and Growth Rate (2017-2022) & (K Units) Figure 39. U.K. Antidiabetic Drug Sales and Growth Rate (2017-2022) & (K Units) Figure 40. Italy Antidiabetic Drug Sales and Growth Rate (2017-2022) & (K Units) Figure 41. Russia Antidiabetic Drug Sales and Growth Rate (2017-2022) & (K Units) Figure 42. Asia Pacific Antidiabetic Drug Sales and Growth Rate (K Units) Figure 43. Asia Pacific Antidiabetic Drug Sales Market Share by Region in 2020 Figure 44. China Antidiabetic Drug Sales and Growth Rate (2017-2022) & (K Units) Figure 45. Japan Antidiabetic Drug Sales and Growth Rate (2017-2022) & (K Units) Figure 46. South Korea Antidiabetic Drug Sales and Growth Rate (2017-2022) & (K Units) Figure 47. India Antidiabetic Drug Sales and Growth Rate (2017-2022) & (K Units) Figure 48. Southeast Asia Antidiabetic Drug Sales and Growth Rate (2017-2022) & (K Units) Figure 49. South America Antidiabetic Drug Sales and Growth Rate (K Units) Figure 50. South America Antidiabetic Drug Sales Market Share by Country in 2020 Figure 51. Brazil Antidiabetic Drug Sales and Growth Rate (2017-2022) & (K Units) Figure 52. Argentina Antidiabetic Drug Sales and Growth Rate (2017-2022) & (K Units) Figure 53. Columbia Antidiabetic Drug Sales and Growth Rate (2017-2022) & (K Units) Figure 54. Middle East and Africa Antidiabetic Drug Sales and Growth Rate (K Units) Figure 55. Middle East and Africa Antidiabetic Drug Sales Market Share by Region in 2020 Figure 56. Saudi Arabia Antidiabetic Drug Sales and Growth Rate (2017-2022) & (K Units) Figure 57. UAE Antidiabetic Drug Sales and Growth Rate (2017-2022) & (K Units) Figure 58. Egypt Antidiabetic Drug Sales and Growth Rate (2017-2022) & (K Units) Figure 59. Nigeria Antidiabetic Drug Sales and Growth Rate (2017-2022) & (K Units) Figure 60. South Africa Antidiabetic Drug Sales and Growth Rate (2017-2022) & (K Units) Figure 61. Global Antidiabetic Drug Sales Forecast by Volume (2017-2028) & (K Units) Figure 62. Global Antidiabetic Drug Market Size Forecast by Value (2017-2028) & (M USD) Figure 63. Global Antidiabetic Drug Sales Market Share Forecast by Type (2022-2028) Figure 64. Global Antidiabetic Drug Market Share Forecast by Type (2022-2028) Figure 65. Global Antidiabetic Drug Sales Forecast by Application (2022-2028) Figure 66. Global Antidiabetic Drug Market Share Forecast by Application (2022-2028)

•Sanofi-Aventis •Eli Lilly •Oramed •Takeda •Boehringer Ingelheim •Novo Nordisk •Halozyme Therapeutics •Bristol-Myers Squibb •Pfizer •Tonghua Dongbao •Biocon •Wockhardt